Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
A recent International Foundation of Employee Benefit Plans survey shows that while employers are open to covering GLP-1 drugs for diabetes, theyre far more hesitant to do so for weight loss
Concomitant Use of Tirzepatide, Ixekizumab Improves PsA Disease Activity and Promotes Weight Reduction Gillian McGovern, Editor Luke Halpern, Associate Editor , Ron Panarotti Key Takeaways The TOGETHER-PsA trial demonstrated superior efficacy of tirzepatide and ixekizumab combination over ixekizumab alone in patients with PsA with obesity or overweight
Medicare/Medicaid Coverage Federal programs: Dont cover weight loss medications by law Cant use manufacturer savings cards Would require full cash price Compounded tirzepatide is more affordable for Medicare/Medicaid patients paying cash
Weekly dose maps one-to-one in milligrams
